Product Information
Hexarelin acetate is a synthetic polypeptide with a molecular weight of 6.5 kDa that is used to treat patients with growth hormone deficiency and Prader-Willi syndrome. Hexarelin acetate was developed using techniques such as drug encapsulation, stakeholders, and thoracoscopy. Hexarelin acetate is administered by intrapulmonary inhalation in microparticle form. The rate of hexarelin acetate encapsulation can be monitored using techniques such as analytical ultracentrifugation, gel chromatography, or radiolabelling. Encapsulated hexarelin acetate has been shown to be a sustainable mode of administration in women with lipoidosis.
Chemical properties
Technical inquiry about: 3D-FH138111 Hexarelin Acetate
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
